NM_000610.4:c.234-905G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000610.4(CD44):c.234-905G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.19 in 152,060 control chromosomes in the GnomAD database, including 3,121 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).
Frequency
Genomes: 𝑓 0.19 ( 3121 hom., cov: 32)
Consequence
CD44
NM_000610.4 intron
NM_000610.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0860
Publications
4 publications found
Genes affected
CD44 (HGNC:1681): (CD44 molecule (IN blood group)) The protein encoded by this gene is a cell-surface glycoprotein involved in cell-cell interactions, cell adhesion and migration. It is a receptor for hyaluronic acid (HA) and can also interact with other ligands, such as osteopontin, collagens, and matrix metalloproteinases (MMPs). This protein participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. Transcripts for this gene undergo complex alternative splicing that results in many functionally distinct isoforms, however, the full length nature of some of these variants has not been determined. Alternative splicing is the basis for the structural and functional diversity of this protein, and may be related to tumor metastasis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.27 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.190 AC: 28832AN: 151942Hom.: 3108 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
28832
AN:
151942
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.190 AC: 28877AN: 152060Hom.: 3121 Cov.: 32 AF XY: 0.190 AC XY: 14113AN XY: 74350 show subpopulations
GnomAD4 genome
AF:
AC:
28877
AN:
152060
Hom.:
Cov.:
32
AF XY:
AC XY:
14113
AN XY:
74350
show subpopulations
African (AFR)
AF:
AC:
11360
AN:
41468
American (AMR)
AF:
AC:
3449
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
482
AN:
3468
East Asian (EAS)
AF:
AC:
224
AN:
5180
South Asian (SAS)
AF:
AC:
583
AN:
4822
European-Finnish (FIN)
AF:
AC:
1981
AN:
10568
Middle Eastern (MID)
AF:
AC:
50
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10275
AN:
67976
Other (OTH)
AF:
AC:
431
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1206
2412
3617
4823
6029
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
496
AN:
3478
ClinVar
Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Calcium oxalate urolithiasis Other:1
Mar 01, 2014
Division of Molecular Genetics and Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University
Significance:association
Review Status:no assertion criteria provided
Collection Method:case-control
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.